Search

everythinglearnresearchcommunity

for

Search:↓

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

New therapies for rare skin diseases show promise but need more research.

Understanding hair growth pathways can lead to better hair loss treatments.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Isoxazole 9 (ISX9) may help regrow hair by activating certain cell signals.

ISX9 helps regrow hair by activating a specific cell signaling pathway.

New treatments for atopic dermatitis and alopecia areata have been developed using a targeted approach.

Targeted cancer therapies can cause new side effects, requiring careful monitoring and management to ensure patient safety.

Microneedles offer a promising, less invasive way to treat and monitor psoriasis.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Targeting colon cancer stem cells might lead to better treatment results.

Peptide-based PROTACs show promise in targeting hard-to-treat proteins, especially for cancer therapy.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.

Peptide drugs now target hard-to-reach proteins more effectively and specifically.

New therapies are being developed that target integrin pathways to treat various diseases.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

Natural small molecules can help treat diseases by activating or inhibiting the Wnt pathway.

Wnt activation shows promise for regenerative medicine but requires selective targeting to minimize risks like cancer.

Small molecules can help turn skin cells into sweat gland-like cells for potential skin repair.

The Wnt/β-catenin pathway helps tissue regeneration but can also cause fibrosis, and drugs that inhibit this pathway may aid in healing skin and heart tissues.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

The research developed new fortilin protein constructs for potential heart disease treatments.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

Targeting Lgr5+ stem cells and Wnt signaling may effectively treat hair loss.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

New treatments for hair loss show promise with advanced therapies and better targeting.